| 1. | Altmedsresearch | |
| 2. | dunnie36 | |
| 3. | bluewatercloud | |
| 4. | sevap476 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | dunnie36 01/25/2018 R.W. Baird reiterates Outperform rating; PT lowered to $253 from $332 |
| 2. | bluewatercloud 02/12/2018 Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients with Compensated Cirrhosis |
| 3. | Altmedsresearch 09/12/2017 investigating claims |
| 4. | Altmedsresearch 02/01/2018 FDA adds Boxed Warning to highlight correct dosing of Ocaliva for patients with a rare chronic liver disease |
| 5. | Altmedsresearch 02/14/2018 $ICPT Earnings today |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Intercept Pharmaceuticals, Inc.
- ICPT
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.